Psychiatry and Neurology, Neurology · Carlsbad, CA
NPI
1619288172
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6010 Hidden Valley Rd Ste 200
Carlsbad, CA, 92011
Phone (760) 631-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$304K
24,200 services
Medicare patients, 2024
717
Average age 74
Drug cost, 2024
$5.8M
1,044 prescriptions
Company payments, 2025
$3,507
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tara A Quesnell was code J0585 (injection, onabotulinumtoxina, 1 unit), 22,000 times for 46 patients. In total Tara A Quesnell billed 24,200 services in 39 codes, and Medicare paid $304K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 22,000 | 46 | $4.91 | $108K |
| 99214 Office E&M - Established | Office | 610 | 386 | $97.95 | $60K |
| 99215 Office E&M - Established | Office | 299 | 230 | $140.57 | $42K |
| 95886 Electrical Nerve Conductivity | Office | 288 | 157 | $83.59 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 239 | 177 | $13.35 | $3,191 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 114 | 98 | $25.28 | $2,882 |
| 64615 Musculoskeletal | Office | 112 | 47 | $123.83 | $14K |
| 95911 Electrical Nerve Conductivity | Office | 82 | 80 | $174.87 | $14K |
| 99205 Office E&M - New | Office | 65 | 65 | $174.37 | $11K |
| 95910 Electrical Nerve Conductivity | Office | 42 | 42 | $152.13 | $6,390 |
| 99213 Office E&M - Established | Office | 31 | 29 | $72.61 | $2,251 |
| 95909 Electrical Nerve Conductivity | Office | 30 | 30 | $113.32 | $3,400 |
| 95923 Electrical Nerve Conductivity | Office | 22 | 22 | $108.88 | $2,395 |
| 95921 Electrical Nerve Conductivity | Office | 14 | 14 | $77.00 | $1,078 |
| 95924 Electrical Nerve Conductivity | Office | 12 | 12 | $131.48 | $1,578 |
By year: 2022 $159K for 7,346 services; 2023 $318K for 25,715 services; 2024 $304K for 24,200 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tara A Quesnell prescribed most often to Medicare patients was Gabapentin, with 148 prescriptions and refills. In total Tara A Quesnell wrote 1,044 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 148 | 318 | 49 | $2,921 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 76 | 81 | Under 11 | $679K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 74 | 74 | Under 11 | $991K |
| Duloxetine Hcl Generic | 61 | 136 | 23 | $1,458 |
| Pyridostigmine Bromide Generic | 59 | 149 | 19 | $5,781 |
| Prednisone Generic | 57 | 120 | 16 | $565 |
| Pregabalin Generic | 34 | 74 | 14 | $1,388 |
| Emgality Pen Galcanezumab-Gnlm | 32 | 42 | Under 11 | $29K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 31 | 31 | Under 11 | $474K |
| Sodium Chloride 0.9 % Sodium Chloride | 30 | 30 | Under 11 | $146 |
| Firdapse Amifampridine Phosphate | 29 | 29 | Under 11 | $1.4M |
| Nortriptyline Hcl Generic | 25 | 56 | Under 11 | $701 |
| Nurtec Odt Rimegepant Sulfate | 20 | 20 | Under 11 | $24K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 16 | 38 | Under 11 | $526 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 16 | 16 | Under 11 | $244K |
Brand drugs: 403 claims; generic drugs: 641 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tara A Quesnell $3,507 ($3,507 in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbvie Inc. with $851.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 34 | $851 |
| UCB, Inc. UCB.BR | 25 | $583 |
| Argenx US, Inc. ARGX | 10 | $353 |
| SK Life Science, Inc. | 18 | $228 |
| Biogen, Inc. BIIB | 13 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $157 |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $135 |
| Harmony Biosciences LLC HRMY | 3 | $112 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $99.49 |
| CSL Behring CSL.AX | 4 | $82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.